The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases

PLoS Pathogens

Volumn 13, Issue 7, 2017, Pages

  Earnest, James T ^a   Hantak, Michael P ^a   Li, Kun ^b   McCray, Paul B ^b   Perlman, Stanley ^b,c   Gallagher, Tom ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CATHEPSIN; CD63 ANTIGEN; CD81 ANTIGEN; CD9 ANTIGEN; CELL RECEPTOR; DIPEPTIDYL PEPTIDASE IV; PROTEINASE; SCAFFOLD PROTEIN; SERINE PROTEINASE; VIRUS SPIKE PROTEIN; VITRONECTIN; CORONAVIRUS SPIKE GLYCOPROTEIN; TMPRSS2 PROTEIN, MOUSE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONAVIRUS INFECTION; ENZYME ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN ADENOVIRUS 5; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOFLUORESCENCE; LIGATION; MEMBRANE MICRODOMAIN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MOUSE; NONHUMAN; PLASMID; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS SPIKE; VIRUS VIRULENCE; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALS; ANTIGENS, CD81; ANTIGENS, CD9; CORONAVIRUS INFECTIONS; DIPEPTIDYL PEPTIDASE 4; HUMANS; MICE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RECEPTORS, VIRUS; SERINE ENDOPEPTIDASES; SPIKE GLYCOPROTEIN, CORONAVIRUS; VIRUS INTERNALIZATION;

EID: 85026872407     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006546     Document Type: Article

References (84)

1. Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, Uhlendorff J, et al. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. Journal of virology. 2010;84(11):5605–14. doi: 10.1128/JVI.00140-10 20237084; PubMed Central PMCID: PMC2876594.
2. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JAT, Retroviral Entry Mediated by Receptor Priming and Low pH Triggering of an Envelope Glycoprotein. Cell. 2000;103(4):679–89. doi: 10.1016/S0092-8674(00)00170-7 11106737
3. Matsuyama S, Taguchi F, Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. Journal of virology. 2009;83(21):11133–41. Epub 2009/08/27. doi: 10.1128/JVI.00959-09 19706706; PubMed Central PMCID: PMCPMC2772765.
4. Dveksler GS, Pensiero MN, Cardellichio CB, Williams RK, Jiang GS, Holmes KV, et al. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. Journal of virology. 1991;65(12):6881–91. Epub 1991/12/01. 1719235; PubMed Central PMCID: PMCPmc250787.
5. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–4. Epub 2003/12/04. doi: 10.1038/nature02145 14647384.
6. Yeager CL, Ashmun RA, Williams RK, Cardellichio CB, Shapiro LH, Look AT, et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature. 1992;357(6377):420–2. Epub 1992/06/04. doi: 10.1038/357420a0 1350662.
7. Raj VS, Mou H, Smits SL, Dekkers DH, Muller MA, Dijkman R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495(7440):251–4. Epub 2013/03/15. doi: 10.1038/nature12005 23486063.
8. Bertram S, Dijkman R, Habjan M, Heurich A, Gierer S, Glowacka I, et al. TMPRSS2 Activates the Human Coronavirus 229E for Cathepsin-Independent Host Cell Entry and Is Expressed in Viral Target Cells in the Respiratory Epithelium. Journal of virology. 2013;87(11):6150–60. doi: 10.1128/JVI.03372-12 23536651
9. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A, et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. Journal of virology. 2013;87(10):5502–11. Epub 2013/03/08. doi: 10.1128/JVI.00128-13 23468491; PubMed Central PMCID: PMCPmc3648152.
10. Glowacka I, Bertram S, Muller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of virology. 2011;85(9):4122–34. Epub 2011/02/18. doi: 10.1128/JVI.02232-10 21325420; PubMed Central PMCID: PMCPmc3126222.
11. Bertram S, Glowacka I, Müller MA, Lavender H, Gnirss K, Nehlmeier I, et al. Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease. Journal of virology. 2011;85(24):13363–72. doi: 10.1128/JVI.05300-11 21994442
12. Magnus C, Rusert P, Bonhoeffer S, Trkola A, Regoes RR, Estimating the Stoichiometry of Human Immunodeficiency Virus Entry. Journal of virology. 2009;83(3):1523–31. doi: 10.1128/JVI.01764-08 19019953
13. Ivanovic T, Choi JL, Whelan SP, van Oijen AM, Harrison SC, Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates. eLife. 2013;2:e00333. doi: 10.7554/eLife.00333 23550179
14. Earnest JT, Hantak MP, Park JE, Gallagher T, Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains. Journal of virology. 2015;89(11):6093–104. Epub 2015/04/03. doi: 10.1128/JVI.00543-15 25833045; PubMed Central PMCID: PMCPmc4442435.
15. Charrin S, le Naour F, Silvie O, Milhiet PE, Boucheix C, Rubinstein E, Lateral organization of membrane proteins: tetraspanins spin their web. The Biochemical journal. 2009;420(2):133–54. doi: 10.1042/BJ20082422 19426143.
16. Stipp CS, Kolesnikova TV, Hemler ME, Functional Domains in Tetraspanin Proteins. Trends in biochemical sciences. 2002;28(2):106–12.
17. Sala-Valdes M, Ursa A, Charrin S, Rubinstein E, Hemler ME, Sanchez-Madrid F, et al. EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. The Journal of biological chemistry. 2006;281(28):19665–75. doi: 10.1074/jbc.M602116200 16690612.
18. Yauch RL, Kazarov AR, Desai B, Lee RT, Hemler ME, Direct Extracellular Contact between Integrin α3β1 and TM4SF Protein CD151. Journal of Biological Chemistry. 2000;275(13):9230–8. doi: 10.1074/jbc.275.13.9230 10734060
19. Yanez-Mo M, Gutierrez-Lopez MD, Cabanas C, Functional interplay between tetraspanins and proteases. Cellular and molecular life sciences: CMLS. 2011;68(20):3323–35. Epub 2011/06/21. doi: 10.1007/s00018-011-0746-y 21687991.
20. Gutierrez-Lopez MD, Gilsanz A, Yanez-Mo M, Ovalle S, Lafuente EM, Dominguez C, et al. The sheddase activity of ADAM17/TACE is regulated by the tetraspanin CD9. Cellular and molecular life sciences: CMLS. 2011;68(19):3275–92. Epub 2011/03/03. doi: 10.1007/s00018-011-0639-0 21365281.
21. Andre M, Le Caer JP, Greco C, Planchon S, El Nemer W, Boucheix C, et al. Proteomic analysis of the tetraspanin web using LC-ESI-MS/MS and MALDI-FTICR-MS. Proteomics. 2006;6(5):1437–49. Epub 2006/01/13. doi: 10.1002/pmic.200500180 16404722.
22. Okamoto T, Iwata S, Yamazaki H, Hatano R, Komiya E, Dang NH, et al. CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells. PloS one. 2014;9(1):e86671. Epub 2014/01/28. doi: 10.1371/journal.pone.0086671 24466195; PubMed Central PMCID: PMCPmc3900581.
23. Zoller M, Tetraspanins: push and pull in suppressing and promoting metastasis. Nature reviews Cancer. 2009;9(1):40–55. Epub 2008/12/17. doi: 10.1038/nrc2543 19078974.
24. Bugge TH, Antalis TM, Wu Q, Type II Transmembrane Serine Proteases. Journal of Biological Chemistry. 2009;284(35):23177–81. doi: 10.1074/jbc.R109.021006 19487698
25. Shirato K, Kawase M, Matsuyama S, Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2. Journal of virology. 2013;87(23):12552–61. doi: 10.1128/JVI.01890-13 24027332
26. Zhao J, Li K, Wohlford-Lenane C, Agnihothram SS, Fett C, Zhao J, et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proceedings of the National Academy of Sciences. 2014;111(13):4970–5. doi: 10.1073/pnas.1323279111 24599590
27. Montpellier C, Tews BA, Poitrimole J, Rocha-Perugini V, D'Arienzo V, Potel J, et al. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection. The Journal of biological chemistry. 2011;286(16):13954–65. Epub 2011/02/24. doi: 10.1074/jbc.M111.220103 21343309; PubMed Central PMCID: PMCPMC3077596.
28. He J, Sun E, Bujny MV, Kim D, Davidson MW, Zhuang X, Dual function of CD81 in influenza virus uncoating and budding. PLoS pathogens. 2013;9(10):e1003701. doi: 10.1371/journal.ppat.1003701 24130495; PubMed Central PMCID: PMC3795033.
29. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F, Genome engineering using the CRISPR-Cas9 system. Nat Protocols. 2013;8(11):2281–308. doi: 10.1038/nprot.2013.143http://www.nature.com/nprot/journal/v8/n11/abs/nprot.2013.143.html#supplementary-information. 24157548
30. Hemler ME, Tetraspanin functions and associated microdomains. Nature reviews Molecular cell biology. 2005;6(10):801–11. doi: 10.1038/nrm1736 16314869.
31. Claas C, Stipp CS, Hemler ME, Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. The Journal of biological chemistry. 2001;276(11):7974–84. doi: 10.1074/jbc.M008650200 11113129.
32. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K-J, Jarvius J, et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Meth. 2006;3(12):995–1000. http://www.nature.com/nmeth/journal/v3/n12/suppinfo/nmeth947_S1.html.
33. Zhou H, Bouwman K, Schotanus M, Verweij C, Marrero JA, Dillon D, et al. Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biology. 2004;5(4):R28. doi: 10.1186/gb-2004-5-4-r28 15059261
34. Grigorov B, Reungoat E, Gentil dit Maurin A, Varbanov M, Blaising J, Michelet M, et al. Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx. Cellular Microbiology. 2016:e12711. doi: 10.1111/cmi.12711 27930836
35. Le Q-T, Blanchet M, Seidah NG, Labonté P, Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9. The Journal of biological chemistry. 2015;290(38):23385–400. doi: 10.1074/jbc.M115.642991. 26195630
36. Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R., Jr.Nunneley JW, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral research. 2015;116:76–84. Epub 2015/02/11. doi: 10.1016/j.antiviral.2015.01.011 25666761; PubMed Central PMCID: PMCPMC4774534.
37. Cockrell AS, Peck KM, Yount BL, Agnihothram SS, Scobey T, Curnes NR, et al. Mouse Dipeptidyl Peptidase 4 Is Not a Functional Receptor for Middle East Respiratory Syndrome Coronavirus Infection. Journal of virology. 2014;88(9):5195–9. doi: 10.1128/JVI.03764-13 24574399
38. Barlan A, Zhao J, Sarkar MK, Li K, McCray PB., Jr.et al. Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. Journal of virology. 2014;88(9):4953–61. Epub 2014/02/21. doi: 10.1128/JVI.00161-14 24554656; PubMed Central PMCID: PMCPmc3993797.
39. Rosenberger CM, Podyminogin RL, Askovich PS, Navarro G, Kaiser SM, Sanders CJ, et al. Characterization of innate responses to influenza virus infection in a novel lung type I epithelial cell model. The Journal of general virology. 2014;95(Pt 2):350–62. Epub 2013/11/19. doi: 10.1099/vir.0.058438-0 24243730; PubMed Central PMCID: PMCPMC3917066.
40. Whitt MA, Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. Journal of virological methods. 2010;169(2):365–74. Epub 2010/08/17. doi: 10.1016/j.jviromet.2010.08.006 20709108; PubMed Central PMCID: PMCPmc2956192.
41. Azhar EI, El-Kafrawy SA, Farraj SA, Hassan AM, Al-Saeed MS, Hashem AM, et al. Evidence for Camel-to-Human Transmission of MERS Coronavirus. New England Journal of Medicine. 2014;370(26):2499–505. doi: 10.1056/NEJMoa1401505 24896817.
42. Marcel AM, Victor Max C, Joerg J, Benjamin M, Mario Y, Anne ML, et al. MERS Coronavirus Neutralizing Antibodies in Camels, Eastern Africa, 1983–1997. Emerging Infectious Disease journal. 2014;20(12):2093. doi: 10.3201/eid2012.141026 25425139
43. Cockrell AS, Yount BL, Scobey T, Jensen K, Douglas M, Beall A, et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nature microbiology. 2016;2:16226. Epub 2016/11/29. doi: 10.1038/nmicrobiol.2016.226 27892925.
44. Li K, Wohlford-Lenane CL, Channappanavar R, Park J-E, Earnest JT, Bair TB, et al. Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proceedings of the National Academy of Sciences. 2017. doi: 10.1073/pnas.1619109114 28348219
45. Shirato K, Kanou K, Kawase M, Matsuyama S, Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry. Journal of virology. 2016;91(1). doi: 10.1128/jvi.01387-16 27733646
46. Banerjee I, Yamauchi Y, Helenius A, Horvath P, High-Content Analysis of Sequential Events during the Early Phase of Influenza A Virus Infection. PloS one. 2013;8(7):e68450. doi: 10.1371/journal.pone.0068450 23874633
47. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P, Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(33):11876–81. doi: 10.1073/pnas.0505577102 16081529
48. Park J-E, Li K, Barlan A, Fehr AR, Perlman S, McCray PB, et al. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism. Proceedings of the National Academy of Sciences. 2016;113(43):12262–7. doi: 10.1073/pnas.1608147113 27791014
49. Zimmerman B, Kelly B, McMillan Brian J, Seegar Tom CM, Dror Ron O, Kruse Andrew C, et al. Crystal Structure of a Full-Length Human Tetraspanin Reveals a Cholesterol-Binding Pocket. Cell. 2016;167(4):1041–51.e11. doi: 10.1016/j.cell.2016.09.056 27881302
50. Takano T, Satomi Y, Oyama Y, Doki T, Hohdatsu T, Differential effect of cholesterol on type I and II feline coronavirus infection. Archives of virology. 2016;161(1):125–33. Epub 2015/10/31. doi: 10.1007/s00705-015-2655-0 26514843.
51. Thorp EB, Gallagher TM, Requirements for CEACAMs and Cholesterol during Murine Coronavirus Cell Entry. Journal of virology. 2004;78(6):2682–92. doi: 10.1128/JVI.78.6.2682-2692.2004 14990688
52. Glende J, Schwegmann-Wessels C, Al-Falah M, Pfefferle S, Qu X, Deng H, et al. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology. 2008;381(2):215–21. http://dx.doi.org/10.1016/j.virol.2008.08.026. 18814896
53. Choi KS, Aizaki H, Lai MMC, Murine Coronavirus Requires Lipid Rafts for Virus Entry and Cell-Cell Fusion but Not for Virus Release. Journal of virology. 2005;79(15):9862–71. doi: 10.1128/JVI.79.15.9862-9871.2005 16014947
54. Nomura R, Kiyota A, Suzaki E, Kataoka K, Ohe Y, Miyamoto K, et al. Human Coronavirus 229E Binds to CD13 in Rafts and Enters the Cell through Caveolae. Journal of virology. 2004;78(16):8701–8. doi: 10.1128/JVI.78.16.8701-8708.2004 15280478
55. Walls AC, Tortorici MA, Bosch B-J, Frenz B, Rottier PJM, DiMaio F, et al. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature. 2016;531(7592):114–7. doi: 10.1038/nature16988http://www.nature.com/nature/journal/v531/n7592/abs/nature16988.html#supplementary-information. 26855426
56. Kirchdoerfer RN, Cottrell CA, Wang N, Pallesen J, Yassine HM, Turner HL, et al. Pre-fusion structure of a human coronavirus spike protein. Nature. 2016;531(7592):118–21. doi: 10.1038/nature17200 26935699
57. Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P, et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013;23(8):986–93. Epub 2013/07/10. doi: 10.1038/cr.2013.92 23835475; PubMed Central PMCID: PMCPMC3731569.
58. Klasse PJ, Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody. Virology. 2007;369(2):245–62. Epub 2007/09/11. doi: 10.1016/j.virol.2007.06.044 17825343; PubMed Central PMCID: PMCPMC2317823.
59. Millet JK, Whittaker GR, Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(42):15214–9. Epub 2014/10/08. doi: 10.1073/pnas.1407087111 25288733; PubMed Central PMCID: PMCPmc4210292.
60. Gierer S, Müller MA, Heurich A, Ritz D, Springstein BL, Karsten CB, et al. Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity. Journal of Infectious Diseases. 2014;211(6):889–97. doi: 10.1093/infdis/jiu407 25057042
61. Belouzard S, Chu VC, Whittaker GR, Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proceedings of the National Academy of Sciences. 2009;106(14):5871–6. doi: 10.1073/pnas.0809524106 19321428
62. Bosch BJ, Bartelink W, Rottier PJ, Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. Journal of virology. 2008;82(17):8887–90. Epub 2008/06/20. doi: 10.1128/JVI.00415-08 18562523; PubMed Central PMCID: PMCPmc2519682.
63. Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, et al. Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated Entry. Journal of virology. 2006;80(12):5768–76. doi: 10.1128/JVI.00442-06 16731916
64. Bohley P, Seglen PO, Proteases and proteolysis in the lysosome. Experientia. 1992;48(2):151–7. Epub 1992/02/15. 1740187.
65. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Krämer-Kühl A, et al. The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies. Journal of virology. 2013;87(10):5502–11. doi: 10.1128/JVI.00128-13 23468491
66. van Meer G, Voelker DR, Feigenson GW, Membrane lipids: where they are and how they behave. Nature reviews Molecular cell biology. 2008;9(2):112–24. doi: 10.1038/nrm2330 18216768
67. Wrensch F, Winkler M, Pohlmann S, IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Viruses. 2014;6(9):3683–98. Epub 2014/09/27. doi: 10.3390/v6093683 25256397; PubMed Central PMCID: PMCPMC4189045.
68. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS pathogens. 2011;7(1):e1001258. doi: 10.1371/journal.ppat.1001258 21253575; PubMed Central PMCID: PMC3017121.
69. Yuan Y, Cao D, Zhang Y, Ma J, Qi J, Wang Q, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. 2017;8:15092. doi: 10.1038/ncomms15092https://www.nature.com/articles/ncomms15092#supplementary-information. 28393837
70. Loffler S, Lottspeich F, Lanza F, Azorsa DO, ter Meulen V, Schneider-Schaulies J, CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. Journal of virology. 1997;71(1):42–9. Epub 1997/01/01. 8985321; PubMed Central PMCID: PMCPmc191022.
71. Krementsov DN, Rassam P, Margeat E, Roy NH, Schneider-Schaulies J, Milhiet P-E, et al. HIV-1 Assembly Differentially Alters Dynamics and Partitioning of Tetraspanins and Raft Components. Traffic. 2010;11(11):1401–14. doi: 10.1111/j.1600-0854.2010.01111.x 20727121
72. Weng J, Krementsov DN, Khurana S, Roy NH, Thali M, Formation of syncytia is repressed by tetraspanins in human immunodeficiency virus type 1-producing cells. Journal of virology. 2009;83(15):7467–74. doi: 10.1128/JVI.00163-09 19458002; PubMed Central PMCID: PMC2708618.
73. Willett B, Hosie M, Shaw A, Neil J, Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism. The Journal of general virology. 1997;78 (Pt 3):611–8. Epub 1997/03/01. doi: 10.1099/0022-1317-78-3-611 9049412.
74. Pique C, Lagaudriere-Gesbert C, Delamarre L, Rosenberg AR, Conjeaud H, Dokhelar MC, Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission. Virology. 2000;276(2):455–65. Epub 2000/10/21. doi: 10.1006/viro.2000.0538 11040136.
75. Wang L, Liu L, Che Y, Wang L, Jiang L, Dong C, et al. Egress of HSV-1 capsid requires the interaction of VP26 and a cellular tetraspanin membrane protein. Virology journal. 2010;7(156). Epub 2010/07/16. doi: 10.1186/1743-422x-7-156 20630051; PubMed Central PMCID: PMCPMC2913958.
76. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, et al. Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor. Journal of Biological Chemistry. 2003;278(43):41624–30. doi: 10.1074/jbc.M305289200 12913001
77. Scheffer KD, Gawlitza A, Spoden GA, Zhang XA, Lambert C, Berditchevski F, et al. Tetraspanin CD151 mediates papillomavirus type 16 endocytosis. Journal of virology. 2013;87(6):3435–46. doi: 10.1128/JVI.02906-12 23302890; PubMed Central PMCID: PMC3592167.
78. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science. 1998;282(5390):938–41. Epub 1998/10/30. 9794763.
79. Krieger SE, Zeisel MB, Davis C, Thumann C, Harris HJ, Schnober EK, et al. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology. 2010;51(4):1144–57. Epub 2010/01/14. doi: 10.1002/hep.23445 20069648.
80. Fénéant L, Levy S, Cocquerel L, CD81 and Hepatitis C Virus (HCV) Infection. Viruses. 2014;6(2):535–72. doi: 10.3390/v6020535. 24509809
81. Scheffer K, Berditchevski F, Florin L, The Tetraspanin CD151 in Papillomavirus Infection. Viruses. 2014;6(2):893. doi: 10.3390/v6020893 24553111
82. Shulla A, Heald-Sargent T, Subramanya G, Zhao J, Perlman S, Gallagher T, A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. Journal of virology. 2011;85(2):873–82. Epub 2010/11/12. doi: 10.1128/JVI.02062-10 21068237; PubMed Central PMCID: PMCPmc3020023.
83. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson BL, A simple method for the rapid generation of recombinant adenovirus vectors. Gene therapy. 2000;7(12):1034–8. Epub 2000/06/29. doi: 10.1038/sj.gt.3301197 10871752.
84. Campbell EM, Perez O, Melar M, Hope TJ, Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology. 2007;360(2):286–93. http://dx.doi.org/10.1016/j.virol.2006.10.025. 17123568